As of April 16, 2025, Cartesian Therapeutics (RNAC) has a market cap of $0.31 billion USD. According to our data, Cartesian Therapeutics is ranked No.6479 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.31 B |
-32.69%
|
Dec 31, 2024 | $0.46 B |
-13.35%
|
Dec 29, 2023 | $0.53 B |
-39.03%
|
Dec 30, 2022 | $0.87 B |
-65.34%
|
Dec 31, 2021 | $2.52 B |
7.59%
|
Dec 31, 2020 | $2.34 B |
27.31%
|
Dec 31, 2019 | $1.84 B |
-10.53%
|
Dec 31, 2018 | $2.05 B |
-72.88%
|
Dec 29, 2017 | $7.57 B |
-42.80%
|
Dec 30, 2016 | $13.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() First Majestic Silver
AG
|
$3.20 B |
0.851 M
|
![]() Canada
|
![]() Sea (Garena)
SE
|
$68.78 B |
5.452 B
|
![]() Singapore
|
![]() Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
![]() USA
|
Market Cap | = | RNAC Stock Price | * | RNAC Shares Outstanding |
= | $11.97 | * | 25.91 M | |
= | $0.31 B |